Leverty Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,014
Closed -$350K 36
2024
Q1
$350K Hold
4,014
0.21% 22
2023
Q4
$331K Hold
4,014
0.21% 22
2023
Q3
$315K Buy
4,014
+208
+5% +$17.4K 0.23% 17
2023
Q2
$335K Hold
3,806
0.24% 18
2023
Q1
$307K Hold
3,806
0.24% 17
2022
Q4
$296K Buy
3,806
+466
+14% +$37.8K 0.25% 20
2022
Q3
$269K Hold
3,340
0.26% 17
2022
Q2
$299K Hold
3,340
0.28% 17
2022
Q1
$370K Hold
3,340
0.29% 15
2021
Q4
$345K Buy
+3,340
New +$387K 0.27% 12

Other funds holding MDT

Leverty Financial Group's MDT Position: Q2 2024 in Review

Leverty Financial Group sold out of Medtronic (MDT) in Q2 2024, closing a stake of 4,014 shares — an estimated $350K sold.

Leverty Financial Group first reported a position in MDT in Q4 2021 and held it in 10 quarters. The position peaked at $370K in Q1 2022. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

  • Leverty Financial Group reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
  • Leverty Financial Group sold 4,014 Medtronic shares in Q2 2024, an estimated $350K.
  • Leverty Financial Group first reported a position in Medtronic in Q4 2021 and held it in 10 quarters.
  • Leverty Financial Group's Medtronic position peaked at $370K in Q1 2022.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on Leverty Financial Group's 13F filing for Q2 2024, filed 15 Jul 2024.